Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8515439rdf:typepubmed:Citationlld:pubmed
pubmed-article:8515439lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C0206293lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C0040679lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C0439742lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C1444748lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C0043309lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C1999230lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:8515439lifeskim:mentionsumls-concept:C1521802lld:lifeskim
pubmed-article:8515439pubmed:issue3lld:pubmed
pubmed-article:8515439pubmed:dateCreated1993-7-20lld:pubmed
pubmed-article:8515439pubmed:abstractTextRecent X-ray crystallographic and solution X-ray scattering studies have shown that transferrins (serum transferrin, lactoferrin and ovotransferrin) undergo a major conformational change when iron is incorporated into the molecule. Apo-proteins show a structure with open interdomain clefts which close when iron is bound. The closed conformation has been suggested as an important step in the receptor recognition. Here, we report X-ray solution scattering experiments of the mutated N-terminal fragment of human serum transferrin with Asp63-->Ser (Cys). The data provide the first direct experimental evidence for the existence of a trigger mechanism for the closure of the interdomain cleft and that this trigger mechanism is disrupted by mutation of Asp63, the only ligand of iron from domain I.lld:pubmed
pubmed-article:8515439pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515439pubmed:languageenglld:pubmed
pubmed-article:8515439pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515439pubmed:citationSubsetIMlld:pubmed
pubmed-article:8515439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8515439pubmed:statusMEDLINElld:pubmed
pubmed-article:8515439pubmed:monthJunlld:pubmed
pubmed-article:8515439pubmed:issn0022-2836lld:pubmed
pubmed-article:8515439pubmed:authorpubmed-author:WoodworthR...lld:pubmed
pubmed-article:8515439pubmed:authorpubmed-author:LindleyP FPFlld:pubmed
pubmed-article:8515439pubmed:authorpubmed-author:HasnainS SSSlld:pubmed
pubmed-article:8515439pubmed:authorpubmed-author:NelFFlld:pubmed
pubmed-article:8515439pubmed:authorpubmed-author:MasonA BABlld:pubmed
pubmed-article:8515439pubmed:authorpubmed-author:GrossmannJ...lld:pubmed
pubmed-article:8515439pubmed:issnTypePrintlld:pubmed
pubmed-article:8515439pubmed:day5lld:pubmed
pubmed-article:8515439pubmed:volume231lld:pubmed
pubmed-article:8515439pubmed:ownerNLMlld:pubmed
pubmed-article:8515439pubmed:authorsCompleteYlld:pubmed
pubmed-article:8515439pubmed:pagination554-8lld:pubmed
pubmed-article:8515439pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:8515439pubmed:meshHeadingpubmed-meshheading:8515439-...lld:pubmed
pubmed-article:8515439pubmed:meshHeadingpubmed-meshheading:8515439-...lld:pubmed
pubmed-article:8515439pubmed:meshHeadingpubmed-meshheading:8515439-...lld:pubmed
pubmed-article:8515439pubmed:meshHeadingpubmed-meshheading:8515439-...lld:pubmed
pubmed-article:8515439pubmed:meshHeadingpubmed-meshheading:8515439-...lld:pubmed
pubmed-article:8515439pubmed:meshHeadingpubmed-meshheading:8515439-...lld:pubmed
pubmed-article:8515439pubmed:meshHeadingpubmed-meshheading:8515439-...lld:pubmed
pubmed-article:8515439pubmed:meshHeadingpubmed-meshheading:8515439-...lld:pubmed
pubmed-article:8515439pubmed:meshHeadingpubmed-meshheading:8515439-...lld:pubmed
pubmed-article:8515439pubmed:meshHeadingpubmed-meshheading:8515439-...lld:pubmed
pubmed-article:8515439pubmed:year1993lld:pubmed
pubmed-article:8515439pubmed:articleTitleAsp ligand provides the trigger for closure of transferrin molecules. Direct evidence from X-ray scattering studies of site-specific mutants of the N-terminal half-molecule of human transferrin.lld:pubmed
pubmed-article:8515439pubmed:affiliationMolecular Biophysics Group, SERC Daresbury Laboratory, Warrington, Cheshire, U.K.lld:pubmed
pubmed-article:8515439pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8515439pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8515439pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8515439lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8515439lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8515439lld:pubmed